Sang Jick Kim
Overview
Explore the profile of Sang Jick Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang J, Choi S, Kim B, Son S, Yoon J, Kim K, et al.
J Nanobiotechnology
. 2025 Jan;
23(1):44.
PMID: 39856746
Passive antibody therapies, typically administered via parenteral routes, have played a crucial role in the initial response to the COVID-19 pandemic. However, the ongoing evolution of SARS-CoV-2 has revealed significant...
2.
Heo C, Lim W, Moon K, Yang J, Kim S, Kim H, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932406
Approved COVID-19 vaccines primarily induce neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the emergence of variants of concern with RBD mutations poses challenges...
3.
Hwang J, Kim B, Moon S, Park W, Kim K, Yoon J, et al.
Adv Healthc Mater
. 2024 Feb;
13(14):e2302803.
PMID: 38329411
The decreasing efficacy of antiviral drugs due to viral mutations highlights the challenge of developing a single agent targeting multiple strains. Using host cell viral receptors as competitive inhibitors is...
4.
Heo C, Lim W, Yang J, Son S, Kim S, Kim D, et al.
Front Immunol
. 2023 Dec;
14:1307693.
PMID: 38143750
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. Numerous virus-neutralizing antibodies...
5.
Park H, Jeong S, Min K, Jung H, Jo S, Byun J, et al.
Plant Biotechnol J
. 2023 Sep;
22(1):10-12.
PMID: 37738279
No abstract available.
6.
Son S, Ahn S, Kim G, Jang Y, Ko C, Kim M, et al.
Antiviral Res
. 2023 Apr;
213:105591.
PMID: 37003306
Influenza A virus continuously infects humans and the antigenic shifts of this respiratory virus enable it to cross the species barrier, threatening public health with the risk of pandemics. Broadly...
7.
Hwang J, Jung Y, Moon S, Yu S, Oh H, Kim S, et al.
Small Methods
. 2022 Feb;
6(4):e2101516.
PMID: 35107214
Many antibody-based antivirals, including broadly neutralizing antibodies (bnAbs) against various influenza virus strains, suffer from limited potency. A booster of the antiviral activity of an antibody is expected to facilitate...
8.
Kang D, Ahn H, Lee J, Kim S, Pyun J, Song C, et al.
Biosens Bioelectron
. 2021 Jun;
190:113369.
PMID: 34098357
Many conventional optical biosensing systems use a single responsive signal in the visible light region. This limits their practical applications, as the signal can be readily perturbed by various external...
9.
Jeong S, Ahn H, Min K, Byun J, Pyo H, Park M, et al.
Int J Mol Sci
. 2021 Apr;
22(9).
PMID: 33919326
For serodiagnosis of foot-and-mouth disease virus (FMDV), monoclonal antibody (MAb)-based competitive ELISA (cELISA) is commonly used since it allows simple and reproducible detection of antibody response to FMDV. However, the...
10.
Jang Y, Shin J, Lee J, Shin H, Kim S, Kim M
Viruses
. 2020 May;
12(5).
PMID: 32466302
Influenza A virus, one of the major human respiratory pathogens, is responsible for annual seasonal endemics and unpredictable periodic pandemics. Despite the clinical availability of vaccines and antivirals, the antigenic...